Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease

Trial Profile

Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Jul 2017

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Cerebrovascular disorders
  • Focus Proof of concept; Therapeutic Use
  • Acronyms PASTIS
  • Most Recent Events

    • 13 Jul 2017 Planned number of patients changed from 54 to 90.
    • 03 Dec 2015 Accrual to date is 14% according to United Kingdom Clinical Research Network
    • 06 Nov 2015 Accrual to date is 12% according to United Kingdom Clinical Research Network
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top